Immunotherapy plus chemo doubles lung cancer survival, study says – Hamilton Journal News
Hamilton Journal News |
Immunotherapy plus chemo doubles lung cancer survival, study says
Hamilton Journal News About 400 of the subjects underwent pembrolizumab, a form of immunotherapy that helps destroy cancer cells; platinum therapy, a procedure that uses cell damaging agents; and pemetrexed, a chemotherapy drug that targets the lungs. The other 200 only … |
